| Name | Title | Contact Details |
|---|
Cerebrio is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Chattem, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Chattanooga, TN. To find more information about Chattem, Inc., please visit www.chattem.com
St. Tammany Parish Hospital delivers today`s life-improving procedures with the latest technology, highest quality and the utmost care to area residents. From wellness and prevention to diagnosis, treatment, rehabilitation and recovery, the St. Tammany Parish Hospital system delivers the very latest technology, the most accomplished specialists and highly personalized, caring staff to ensure patients and their families receive world-class healthcare close to home. St. Tammany has higher quality ratings from The Joint Commission (qualitycheck.org) than other hospitals in our region. STPH consistently earns national and local recognition for quality, innovation and patient satisfaction from Press Ganey, Reuters Thomson, VHA Leadership Awards, Employer of Choice, Best Places to Work and Best of the Northshore rankings. Please tell any member of the staff, a supervisor or the Guest Services Department (898-4669) if there is anything we can do to make a patient`s stay more comfortable. We want the opportunity to address it. St. Tammany Parish Hospital is accredited by The Joint Commission, whose standards deal with quality and safety of care and environment. Patients have the right to contact the Joint Commission`s Office of Quality Monitoring for concerns about your care either by calling (800) 994-6610 or by visiting jointcommission.org/. You may also speak with the Louisiana Department of Health and Hospitals by calling (225) 342-6429 or the U.S. Department of Health and Human Services at (877) 696-6775. St. Tammany Parish Hospital campuses are completely tobacco-free. As the largest healthcare provider in the parish, we eliminated tobacco as part of our mission to serve the community`s healthcare needs. We recognize adults` right to use tobacco but we know its ill effects and institute this policy for the safety and health of our patients, families, employees, volunteers and physicians. Thank you for not smoking. STPH is a self-supporting not-for-profit community hospital; it receives no tax funding.
We bring the hospital to you! We deliver advanced medical care to where and when patients and their families want and need it. The Medically Home Program gives you more care over a longer period of time. We know getting well from a hospital-level illness or surgical procedure takes weeks, not days. With the Medically Home Program, you get the time you need - at home - with a single care team available to you the entire time. One of the secrets to getting better is being involved in – and understanding – your own care. The more time you and your family spend with our clinical care team, the more tools you will have to be get better. We know it can be hard for you to deal with medication, nutrition, stress and other health issues. The relationship we build during our time together will help us support your goal of getting better. Having the time to get to know you and your family is a big part of how we deliver care, because you really matter.
ForSight VISION5, Inc. (www.forsightvision5.com), was founded in January of 2011 as the fifth company to emerge from the ophthalmic incubator ForSight Labs, LLC (www.forsightlabs.com). ForSight VISION5 is focused on developing non-invasive drug delivery products that replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. ForSight VISION5`s lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to receive medication continually. The Helios insert is restricted to investigational use only and has not been approved by the Food and Drug Administration or any other regulatory authority for commercial distribution.